 Disease Progression
"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 13 | 13 | | 1999 | 0 | 13 | 13 | | 2000 | 0 | 14 | 14 | | 2001 | 0 | 12 | 12 | | 2002 | 0 | 17 | 17 | | 2003 | 0 | 33 | 33 | | 2004 | 0 | 27 | 27 | | 2005 | 0 | 39 | 39 | | 2006 | 1 | 41 | 42 | | 2007 | 2 | 55 | 57 | | 2008 | 2 | 67 | 69 | | 2009 | 4 | 56 | 60 | | 2010 | 4 | 72 | 76 | | 2011 | 7 | 57 | 64 | | 2012 | 3 | 75 | 78 | | 2013 | 4 | 87 | 91 | | 2014 | 6 | 70 | 76 | | 2015 | 8 | 95 | 103 | | 2016 | 9 | 90 | 99 | | 2017 | 10 | 120 | 130 | | 2018 | 6 | 111 | 117 | | 2019 | 11 | 130 | 141 | | 2020 | 3 | 111 | 114 | | 2021 | 9 | 81 | 90 | | 2022 | 0 | 54 | 54 | | 2023 | 2 | 59 | 61 | | 2024 | 30 | 57 | 87 | | 2025 | 6 | 76 | 82 | | 2026 | 5 | 47 | 52 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Wu X, Zhang M, Moon JS, Song EK, Abrams JC, van Dam LS, Sharpe O, Wang Z, Feser ML, Moss L, Ho PP, Smith MH, Donlin LT, Buckner JH, James EA, Firestein GS, Okamoto Y, Lanz TV, Meffre E, Lyu A, Holers VM, Deane KD, Robinson WH. Senescent-like activated naive B cells contribute to progression to clinical rheumatoid arthritis. Nat Aging. 2026 Oct; 6(10):2143-2163.
-
de Carlo Forest TE, Grove NC, Cordaro N, Advaith Veturi Y, Wagner BD, Manoharan N, Lisker-Cervantes A, Bearce B, McNamara S, Lynch A, Kalpathy-Cramer J, Palestine AG, Mathias M, Holers VM, Mandava N. Latent Correlations Between Longitudinal Systemic Complement Factors and Geographic Atrophy Growth Rate. Invest Ophthalmol Vis Sci. 2026 Oct 01; 67(12):69.
-
Khunti K, Funnell MP, Highton PJ, Ardavani A, Butler J, Campbell J, Davies MJ, Evley R, Florez JC, Gaglia J, Kulkarni RN, Musi N, Perreault L, Reeve BB, Rosas SE, Routen A, Younossi Z, El Sayed N. Disease modification outcomes in type 2 diabetes: a modified Delphi. Lancet Diabetes Endocrinol. 2026 Nov; 14(11):970-978.
-
Mack CL, Miethke AG, Hawthorne K, Henn L, Horslen S, Alonso EM, Gupta NA, Sundaram SS, Kohli R, Bozic M, Deneau M, Guthery S, Loomes KM, Valentino PL, Tessier MEM, Shneider B, Magee JC, Karpen S, Rosenthal P, Wang K, Ricciuto A, Sokol RJ, Kamath BM. The Childhood Liver Disease Research Network's prospective characterization of pediatric primary sclerosing cholangitis. Hepatol Commun. 2026 Oct 01; 10(10).
-
Valença-Pereira F, Johnson B, DeGregori J, Rincon M. Does acute inflammation triggered by infection promote cancer progression? PLoS Biol. 2026 Sep; 24(9):e3003962.
-
Lange AV, Tietbohl C, Klocko RP, Bekelman DB, Mehta AB. Veterans' Perspectives on Serious Illness Communication About Lung Disease Progression. Mil Med. 2026 Sep 01; 191(9-10):e2021-e2029.
-
Mikeska RG, Feldman LER, Woodruff ER, Iwanaga R, Linder KE, Yamamoto TM, Sompel K, Jordan KR, Post MD, Zoller M, Bitler BG, Marjon NA. Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma. Cancer Res Commun. 2026 Sep 01; 6(9):2256-2270.
-
Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2026 Sep; 27(9):1094-1109.
-
Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026 Sep 01; 9(9):e2634809.
-
Phung Khanh L, Rosenberger KD, Dong Thi Hoai T, Nguyen Tan Thanh K, Tran Van N, Nguyen Tran N, Do Chau V, Nguyen Van K, Yacoub S, Chanpheaktra N, Kumar V, Lum Chai See L, Sathar J, Sandoval EP, Marón GM, Laksanawati IS, Mahendradhata Y, Hassan MZ, Ahmed F, Caprara A, Benevides BS, Marques ETA, Magalhaes T, Brasil P, Netto M, Tami A, Bethencourt SE, Guzman MG, Simmons C, Nguyen Than Ha Q, Wolbers M, Geskus RB, Jaenisch T, Wills B. Improving early prediction for adverse dengue outcomes using data from the IDAMS prospective multicentre study. Nat Commun. 2026 08 21; 17(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|